Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
250 Frankfurter Straße, Darmstadt, HE, 64293, DE
Enabling an Optimized Approach for Formulation of Poorly Soluble Molecules
Released By Merck
Protein viscosity is one of the major obstacles in preparing highly concentrated protein formulations. This white paper evaluates viscosity-reducing capacities.
Dry granulation can be a method to overcome caking issues and improve handling of buffers, salts and stabilizing chemicals during pharmaceutical manufacturing.
In this white paper, the use of 3D printing is explored, with a focus on enhancement of bioavailability of APIs in solid dispersions.
Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.
Download the FREE White Paper Released by MilliporeSigma.
Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1.
By: Rachel Klemovitch
The companies partner on antibody drug conjugates, drug substance, and drug product manufacturing services.
How the effectiveness, flexibility and sustainability of single-use technologies solve many of today’s challenges in biomanufacturing.
Shiva Krupa also joins as Vice President of Program Management.
The companies will evaluate the combination of ATG-022 and MSD's anti-PD-1 therapy, KEYTRUDA, in patients with advanced solid tumors.
Dr. Conrad brings over 30 years of experience spanning R&D, strategy and operations, business and corporate development, alliance management, and finance.
Will comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies.
By: Charlie Sternberg
Will strengthen the presence of the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States.
Ania W. Payne, PhD, will be responsible for developing a global growth strategy in collaboration with the whole executive team.
Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.
New appointments will provide the company with broader expertise in regulatory affairs, clinical development and commercialization.
MSD gained a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics.
Michael Mellor-Clark will work with Upperton’s leadership team and board to drive the commercial strategy and guide the next stage of Upperton’s growth.
Merck’s subcutaneous pembrolizumab with berylluronidase alfa shows noninferior pharmacokinetics to intravenous KEYTRUDA in pivotal trial.
Novartis cuts approximately 430 employees from East Hanover HQ, and 34 employees in San Diego.
By: Kristin Brooks
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
